Insulin (medication) testing and occasionally skin biopsy. First line therapy against insulin hypersensitivity reactions include symptomatic therapy with antihistamines. The affected persons are then switched to a preparation that does not contain the specific agent they are reacting to or undergo desensitization. Insulin is an endogenous hormone, which is produced by the pancreas. The insulin protein has been highly conserved across evolutionary time, and is present in both mammals and invertebrates. The insulin/insulin-like growth factor signalling pathway (IIS) has been extensively studied in species including nematode worms (e.g."C. elegans"), flies ("Drosophila melanogaster") and mice ("Mus musculus"). Its mechanisms of action are highly
Braasch Biotech intellectual property positions by multiple filings and anticipates several additional filings to support their technology. Somatostatin (also known as Growth Hormone Inhibiting Hormone) is the main regulator for the release of Growth Hormone (GH) from the pituitary gland, which leads to several body functions including an increase of IGF-1 (Insulin-like Growth Factor 1) levels. Somatostatin inhibits the actions of Growth Hormone-Releasing Hormone, also a hypothalamus hormone, which controls the release of Growth Hormone. Braasch's Somatostatin vaccine technology allows the immune system to temporarily reduce, but not completely eliminate, the mostly inhibitory actions of Somatostatin. The vaccination effect causes more Growth